GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (STU:NR1A) » Definitions » Capex-to-Revenue

National Research (STU:NR1A) Capex-to-Revenue : 0.12 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is National Research Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

National Research's Capital Expenditure for the three months ended in Mar. 2024 was €-3.81 Mil. Its Revenue for the three months ended in Mar. 2024 was €32.49 Mil.

Hence, National Research's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.12.


National Research Capex-to-Revenue Historical Data

The historical data trend for National Research's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Capex-to-Revenue Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.04 0.07 0.11

National Research Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.12 0.12 0.10 0.12

Competitive Comparison of National Research's Capex-to-Revenue

For the Health Information Services subindustry, National Research's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where National Research's Capex-to-Revenue falls into.



National Research Capex-to-Revenue Calculation

National Research's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-14.469) / 136.248
=0.11

National Research's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-3.807) / 32.488
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (STU:NR1A) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


National Research Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of National Research's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (STU:NR1A) Business Description

Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.

National Research (STU:NR1A) Headlines

No Headlines